ArticleJHEP reports : innovation in hepatology2024

HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative.

Tai-Chung Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.